Midlife Inflammation Tied to Slowing of Gait Speed in Later Life
By Lori Solomon HealthDay Reporter
FRIDAY, June 14, 2024 -- Inflammation in midlife may contribute to clinically meaningful late-life slowing of gait speed, according to a study published online June 12 in the Journal of the American Geriatrics Society.
Kirby G. Parker, M.D., from the University of Mississippi Medical Center in Jackson, and colleagues examined the relationship between midlife inflammation and late-life mobility, along with the influences of chronic health conditions, race, and social determinants of health (SDoH). Analysis included 4,758 community-dwelling participants with high-sensitivity C-reactive protein (hsCRP) measured in midlife at study visit 2 (1990–1992; 47 to 68 years); at visit 4 (1996 to 1998; 53 to 74 years); and late-life (visit 5: 2011 to 2013; mean 75 years).
The researchers found that high midlife hsCRP was associated with slower late-life gait speed, even among those without chronic conditions in midlife (−4.6 cm/second). Among those who never experienced obesity, diabetes, or hypertension, sustained high hsCRP was associated with a 20-year slowing of −10.0 cm/second. Findings were similar for both Black participants (−3.8 cm/second) and White participants (−3.3 cm/second) per interquartile range of midlife hsCRP. Chronic conditions and race had no effect modifications throughout. In all participants, worse SDoH was associated with higher inflammation and slower gait speed.
"Regular monitoring of inflammation during wellness visits and other preventative programs may be warranted for all people, adding value alongside other common chronic condition measures," the authors write.
One author disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-06-15 03:15
Read more
- ASN: Atrasentan Significantly and Clinically Meaningfully Cuts Proteinuria
- Rates of Anxiety, Depression Rising Among Americans, Especially the Young
- Adult Hypertension Prevalence 47.7 Percent From August 2021 to August 2023
- Botox Cosmetic (onabotulinumtoxinA) Receives FDA Approval for Moderate to Severe Vertical Bands Connecting the Jaw and Neck (Platysma Bands)
- Cutaneous Malignant Melanoma Incidence Increasing Among the Elderly
- Patient-Reported Lumbar Symptom Information Beneficial for Radiologists
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions